2025 - Introduced
Alabama S.B. 161
  • Requires that non-opioid drugs approved by the FDA are included on the preferred drug list with terms of coverage that are no less restrictive than those given to opioids on the preferred drug list.
Medicaid Parity
Read Bill
2026 - Introduced
Arizona H.B. 2725
  • Amends Arizona's Medicaid program to prohibit health plans from substituting an opioid when a physician prescribes a non-opioid drug for pain treatment.
  • Bars the state from imposing more restrictive utilization controls, like prior authorization or step therapy, on non-opioid pain medications.
Medicaid Parity
Read House Bill
2025 - Introduced
Arizona H.B. 2823
  • Ensures that a non-opioid drug approved by the FDA is not disadvantaged or discouraged with respect to coverage relative to an opioid for the treatment or management of pain on the state drug formulary.
Medicaid Parity
Read Bill
2025 - Passed
Arkansas H.B.1186
  • Provides for equal access to non-opioid pain relief options alongside opioid treatments within Arkansas' Medicaid program.
Medicaid Parity
Read Bill
2026 - Introduced
Colorado S.B. 26-006
  • Requires health insurers and Colorado Medicaid to treat FDA-approved non-opioid pain medications at least as favorably as opioids by limiting prior authorization and step therapy, ensuring non-opioid alternatives are available, and prohibiting higher cost-sharing.
  • Aims to promote non-opioid pain management by removing financial and administrative barriers.
Medicaid ParityState Employee Health Plan Parity
Read Senate Bill
2025 - Introduced
Florida H.B. 1093/S.B. 1154
  • Prohibits Medicaid from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioids, including by establishing utilization controls for a non-opioid that are more restrictive or more extensive than the least restrictive or extensive utilization controls for any opioid.
Medicaid Parity
Read House BillRead Senate Bill
2025 - Introduced
Illinois H.B. 2852
  • Prohibits a health insurer to deny coverage of a non-opioid prescription drug in favor of an opioid prescription drug and requires that nonopioid drugs preferred on a specific list for the treatment or management of pain shall not be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of pain.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Passed
Illinois S.B.1238
  • Prohibits a health insurer from denying coverage of a non-opioid in favor of an opioid and requires that in establishing a drug formulary, health insurers must ensure a non-opioid is not disadvantaged or discouraged with respect to coverage of an opioid. The bill also allows the Illinois Department of Public Health to develop and publish non-opioid educational resources.
Medicaid ParityState Regulated Commercial ParityEducation
Read Bill
2025 - Introduced
Indiana H.B. 1358
  • Prohibits stricter coverage restrictions under Medicaid and the Children’s Health Insurance Program for FDA-approved non-opioids compared to opioids to treat or manage pain. The bill also prohibits health insurers and health maintenance organization contracts from applying greater coverage restrictions on non-opioid prescribed drugs than to opioid drugs.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Iowa HSF 151
  • Requires that a non-opioid drug approved by the FDA is not disadvantaged or discouraged with respect to Medicaid coverage relative to an opioid on the preferred drug list.
  • Prohibits health insurers from establishing utilization controls for non-opioid drugs approved by the FDA that are more restrictive or extensive than the least restrictive or extensive utilization controls for any opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Kansas H.B. 2364
  • Requires state health programs to cover non-opioid pain medications without requiring patients to try opioids first and without less favorable coverage or higher cost-sharing than opioids.
  • Prohibits formularies from disadvantaging FDA-approved non-opioid pain treatments through stricter utilization controls or tier placement.
Medicaid ParityState Employee Health Plan Parity
Read House Bill
2026 - Introduced
Kentucky S.B. 56
  • Prohibits the Kentucky Department for Medicaid Services, Medicaid managed care organizations, and the Medicaid pharmacy benefit manager from denying coverage of a prescribed non-opioid in favor of an opioid drug for the treatment of acute pain.
Medicaid Parity
Read Senate Bill